US Residents Only

Get More Of What Matters With Zokinvy®

Zokinvy is the first and only treatment to target the cause and symptoms of progeria, also known as Hutchinson-Gilford progeria syndrome, and processing-deficient progeroid laminopathies (PDPL) in young people 12 months of age and older.

Michiel, 21, Belgium. Photo courtesy of The Progeria Research Foundation.

Connect with Eiger OneCare

Get in touch with your dedicated team of specialists to see what they can do for your family.

Connect Now

Learn about Zokinvy

Zokinvy was studied in clinical trials to ensure its safety and effectiveness.

Looking for more information?

Get downloadable materials and links to advocacy groups on our resources page.

Learn More
Amen, 21, Togo. Photo courtesy of The Progeria Research Foundation.


Do not take ZOKINVY if you are taking:

  • a strong or moderate CYP3A inhibitor or inducer
  • midazolam
  • lovastatin, simvastatin, and atorvastatin

WHAT IS Zokinvy® (lonafarnib)?

ZOKINVY (zoh-KIN-vee) is a prescription medicine used to treat Hutchinson-Gilford Progeria Syndrome and some types of Progeroid Laminopathies known as processing-deficient Progeroid Laminopathies. These illnesses are caused when the body makes harmful proteins called progerin and progerin-like proteins.